Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Other Operating Expenses (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Other Operating Expenses for 2 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 88.61% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 88.86% year-over-year, with the annual reading at $2.4 million for FY2025, 88.86% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $2.4 million at Pyxis Oncology, down from $21.0 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $21.0 million in Q4 2024, with the low at $475000.0 in Q1 2024.